February 2023: $ $ Circulating Tumor DNA Profiling for Detection, Risk Stratification, and Classification of Brain Lymphomas
Paper: Journal of Clinical Oncology
Autor: PD Dr. Florian Scherer
Institution: Department of Hematology, Oncology and Stem Cell Transplantation, University Medical Center Freiburg, Freiburg University
January 2023: $ $ MHC class II-restricted antigen presentation is required to prevent dysfunction of cytotoxic T cells by blood-borne myeloids in brain tumors
Paper: Cancer Cell
Author: Dr. med. Dr. rer. nat. Lukas Bunse
Institution: Neurology Clinic, Medical Faculty Mannheim, University Heidelberg and Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center Heidelberg.
MYB orchestrates T cell exhaustion and response to checkpoint inhibition.
Paper: Nature
Author: Dr. Veit Buchholz
Institution: Institute for Medical Microbiology, Immunology and Hygiene, Technical University of Munich
Glioblastoma hijacks neuronal mechanisms for brain invasion.
Paper: Cell
Author: Dr. med. Dr. rer. nat. Varun Venkataramani
Institution: Department of Neurology, Unversity Clinic Heidelberg
Superparamagnetic Iron Oxide Nanoparticles for Targeted Cell Seeding: Magnetic Patterning and Magnetic 3D Cell Culture.
Paper: Advanced Functional Materials
Author: Christina Janko
Institution: Section of Experimental Oncology and Nanomedicine (SEON), Department of Otorhinolaryngology, Universitätsklinikum Erlangen
Spatially resolved multi-omics deciphers bidirectional tumor-host interdependence in glioblastoma.
Paper: Cancer Cell
Author: PD Dr. Dieter Henrik Heiland
Institution: Department of Neurosurgery, University of Freiburg